Login

DLTx's website hosts interviews with key figures like James Haft, Chairman, and Joe Davy, Founder, Chairman, emphasizing insights into their blockchain initiatives. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Welcome to Precedent Asset Management with Kenneth Kola Bundy
00:10:00
help technical founders turn machine learning models|Mark Gorenberg,Managing Director,Zetta Venture Partners
00:10:00
Karim Awad on EFG Hermes' Acquisition of 51% Stake in AIB and Transformation to Universal Bank | Karim Awad , CEO, Egypt EFG Hermes.
00:10:00
Exploration Plans for White Cliff Minerals' Projects
00:10:00
CEO Thomas Schulz on Bilfinger's Q2 Earnings, Europe's Energy Crisis, and Cost Pressures | Thomas Schulz - CEO of Bilfinger
00:10:00
Unlocking Freedom and Wealth: The Power of the 10X Mindset | Curt Stowers, Founder , F5 Financial Planning.
00:10:00
Anne Meara Co: Navigating Career Transitions and Making a Meaningful Impact in Silicon Valley|Ann Miura-Ko,co-founding Partner at Floodgate
00:10:00
Michelle Xia on Akeso's Rapid Expansion and Groundbreaking Drug Development | Michelle Xia, CEO, Akeso Inc.
00:10:00
Focus on B2B Fintech web3 digital health Not-so-hot sectors: Consumer marketplaces e-commerce|Eric Bahn,General Partner,Hustle Fund
00:00:00
Allergy Therapeutics says US preparations are underway which include two pivotal trials - Manuel Llobert, CEO, Allergy Therapeutics
00:10:00
Enhancing Returns by Avoiding Extreme Market Volatility
00:10:00
Bessemer supports founders and CEOs from their early days through every stage of growth|Amit Karp,Partner,Bessemer Venture Partners

© 2026 Nehu